MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) Return on equity 2019–2025
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
3.6%FY2025 · since FY2019: 25.9% → 3.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3.6% | -3.2 pp |
| FY2024 | 6.8% | -1.1 pp |
| FY2023 | 7.9% | +3.4 pp |
| FY2022 | 4.5% | -14.9 pp |
| FY2021 | 19.4% | -3.0 pp |
| FY2020 | 22.5% | -3.4 pp |
| FY2019 | 25.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice